PRISM BioLab > News > PRISM Biolab and Boehringer Ingelheim enter multi-project drug discovery collaboration

PRISM Biolab and Boehringer Ingelheim enter multi-project drug discovery collaboration

June 8, 2020 By vera

PRISM Biolab provides The PRISM Library, proprietary library of peptide mimetic small molecules for screening against Boehringer Ingelheim’s novel targets

Read Full Press Release

English

PRISM Biolab and Boehringer Ingelheim enter multi-project drug discovery collaboration

PRISM is open to all levels of scientific discussion. Our scientists would love to speak with you!